Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 143,933 |
|
|||||
| News | - | ||||||
| Day High | 0.27 | Low High |
|||||
| Day Low | 0.2561 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| China Pharma Holdings Inc | CPHI | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0139 | -5.07% | 0.26 | 18:38:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.266 | 0.2561 | 0.27 | 0.2579 | 0.273899 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 357 | 143,933 | US$ 0.26076 | US$ 37,532 | - | 0.2561 - 2.05 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 100 | US$ 0.2579 | USD |
China Pharma Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.96M | 11.40M | - | 7.03M | -3.08M | -0.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
China Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/30/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/15/2024 | 15:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/08/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/23/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/23/2024 | 15:05 | PR Newswire (US) | China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock.. |
| 2/14/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 2/08/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/06/2024 | 15:16 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
| 1/26/2024 | 16:04 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 1/12/2024 | 15:05 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 1/12/2024 | 13:42 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 12/21/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPHI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.274 | 0.2869 | 0.2561 | 0.2698368 | 223,791 | -0.014 | -5.11% |
| 1 Month | 0.3784 | 0.41 | 0.2561 | 0.3176695 | 763,139 | -0.1184 | -31.29% |
| 3 Months | 0.39 | 0.44 | 0.2561 | 0.3253253 | 466,510 | -0.13 | -33.33% |
| 6 Months | 0.525 | 0.688 | 0.2561 | 0.4468864 | 1,077,264 | -0.265 | -50.48% |
| 1 Year | 1.90 | 2.05 | 0.2561 | 0.6565281 | 1,611,568 | -1.64 | -86.32% |
| 3 Years | 35.995 | 48.50 | 0.2561 | 7.77 | 1,053,359 | -35.74 | -99.28% |
| 5 Years | 14.325 | 81.50 | 0.2561 | 20.92 | 1,218,336 | -14.07 | -98.18% |
China Pharma Description
| China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others. |
